TIGENIX : European Medicines Agency accepts TiGenix Paediatric Investigation Plan for Cx601
(4-traders.com) Leuven (BELGIUM) - 8 September, 2014 -TiGenix NV (Euronext Brussels: TIG), an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from its proprietary platform of allogeneic, expanded adipose-derived stem cells, or eASC's, in inflammatory a ...
‘WESTERN FIGHTERS’ IN THE MIDDLE EAST
Intelligence Study The issue of foreign fighters’ participation with extremist groups in the Middle East was brought to the agenda after the Islamic State — formerly known as the Islamic State of Levant and Iraq – gained control of Mosul, Iraq’s second largest city in June. Anadolu Agency reporters ...
Twitter, an incentive to keep communications going
The European Commission’s EMPL presence on Twitter in 2012: Conclusions Introduction This set of articles reports on the 2012 Twitter communications of the European Commission’s Directorate-General for Employment, Social Affairs and Inclusion (DG EMPL). The research focused on their communication co ...
Other Things Happen around McCackcaul farm
The de-feathered hens are receiving a handful of mature mealworms a couple times per week. But they are not eating ALL the mealworms. Some of the worms are turning to pupaes then beetles, so the circle/cycle moves around with time. I keep each group separate. The pupaes, as they form, I pull out of ...
ThromboGenics' JETREA(R) Gains Approval In South Korea
LEUVEN, Belgium, Sept. 8, 2014 (GLOBE NEWSWIRE) -- ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, today announces that JETREA ® (ocriplasmin ...
